To further validate the aberrant ENO1 expression in BLCA, western blotting was performed and increase of ENO1 protein level was detected in 13 out of 16 paired noncancerous and BLCA tissue samples (p = 0.001, Fig. 4A, B). This evidence concerns the gene ENO1 and bladder transitional cell carcinoma.